Logo image of HOLX

HOLOGIC INC (HOLX) Stock Fundamental Analysis

NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD

64.78  -0.52 (-0.8%)

After market: 64.78 0 (0%)

Fundamental Rating

6

Overall HOLX gets a fundamental rating of 6 out of 10. We evaluated HOLX against 187 industry peers in the Health Care Equipment & Supplies industry. HOLX gets an excellent profitability rating and is at the same time showing great financial health properties. HOLX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

HOLX had positive earnings in the past year.
In the past year HOLX had a positive cash flow from operations.
Each year in the past 5 years HOLX has been profitable.
In the past 5 years HOLX always reported a positive cash flow from operatings.
HOLX Yearly Net Income VS EBIT VS OCF VS FCFHOLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of HOLX (6.51%) is better than 88.24% of its industry peers.
HOLX has a better Return On Equity (12.05%) than 88.24% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.33%, HOLX belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.
HOLX had an Average Return On Invested Capital over the past 3 years of 11.66%. This is above the industry average of 7.89%.
Industry RankSector Rank
ROA 6.51%
ROE 12.05%
ROIC 10.33%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
HOLX Yearly ROA, ROE, ROICHOLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

HOLX has a Profit Margin of 13.83%. This is amongst the best in the industry. HOLX outperforms 91.44% of its industry peers.
HOLX's Profit Margin has declined in the last couple of years.
HOLX has a better Operating Margin (24.43%) than 94.65% of its industry peers.
HOLX's Operating Margin has improved in the last couple of years.
HOLX has a Gross Margin of 56.44%. This is comparable to the rest of the industry: HOLX outperforms 55.08% of its industry peers.
HOLX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.43%
PM (TTM) 13.83%
GM 56.44%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
HOLX Yearly Profit, Operating, Gross MarginsHOLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HOLX is still creating some value.
The number of shares outstanding for HOLX has been reduced compared to 1 year ago.
The number of shares outstanding for HOLX has been reduced compared to 5 years ago.
HOLX has a better debt/assets ratio than last year.
HOLX Yearly Shares OutstandingHOLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
HOLX Yearly Total Debt VS Total AssetsHOLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

HOLX has an Altman-Z score of 3.87. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.87, HOLX is in the better half of the industry, outperforming 72.19% of the companies in the same industry.
The Debt to FCF ratio of HOLX is 2.61, which is a good value as it means it would take HOLX, 2.61 years of fcf income to pay off all of its debts.
HOLX has a Debt to FCF ratio of 2.61. This is amongst the best in the industry. HOLX outperforms 89.30% of its industry peers.
A Debt/Equity ratio of 0.54 indicates that HOLX is somewhat dependend on debt financing.
HOLX has a worse Debt to Equity ratio (0.54) than 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 2.61
Altman-Z 3.87
ROIC/WACC1.27
WACC8.12%
HOLX Yearly LT Debt VS Equity VS FCFHOLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

HOLX has a Current Ratio of 3.24. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of HOLX (3.24) is comparable to the rest of the industry.
A Quick Ratio of 2.52 indicates that HOLX has no problem at all paying its short term obligations.
HOLX has a Quick ratio (2.52) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 2.52
HOLX Yearly Current Assets VS Current LiabilitesHOLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.83% over the past year.
HOLX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.83% yearly.
HOLX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.66%.
HOLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.66% yearly.
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%

3.2 Future

HOLX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.71% yearly.
HOLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.75% yearly.
EPS Next Y4.53%
EPS Next 2Y6.28%
EPS Next 3Y7.67%
EPS Next 5Y5.71%
Revenue Next Year1.24%
Revenue Next 2Y3.06%
Revenue Next 3Y3.78%
Revenue Next 5Y4.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HOLX Yearly Revenue VS EstimatesHOLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
HOLX Yearly EPS VS EstimatesHOLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.69, which indicates a correct valuation of HOLX.
84.49% of the companies in the same industry are more expensive than HOLX, based on the Price/Earnings ratio.
HOLX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.45.
The Price/Forward Earnings ratio is 14.06, which indicates a correct valuation of HOLX.
Based on the Price/Forward Earnings ratio, HOLX is valued cheaply inside the industry as 85.56% of the companies are valued more expensively.
HOLX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.69
Fwd PE 14.06
HOLX Price Earnings VS Forward Price EarningsHOLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HOLX is valued cheaper than 88.77% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HOLX is valued cheaply inside the industry as 91.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.88
EV/EBITDA 11.83
HOLX Per share dataHOLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HOLX does not grow enough to justify the current Price/Earnings ratio.
HOLX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.46
PEG (5Y)1.45
EPS Next 2Y6.28%
EPS Next 3Y7.67%

More info and screens

0

5. Dividend

5.1 Amount

HOLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOLOGIC INC

NASDAQ:HOLX (7/3/2025, 7:34:10 PM)

After market: 64.78 0 (0%)

64.78

-0.52 (-0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners102.68%
Inst Owner Change-2.29%
Ins Owners0.78%
Ins Owner Change0.4%
Market Cap14.44B
Analysts70
Price Target68.28 (5.4%)
Short Float %2.28%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.62%
Min EPS beat(2)-0.63%
Max EPS beat(2)-0.62%
EPS beat(4)1
Avg EPS beat(4)-0.3%
Min EPS beat(4)-2.26%
Max EPS beat(4)2.31%
EPS beat(8)5
Avg EPS beat(8)1.16%
EPS beat(12)9
Avg EPS beat(12)8.52%
EPS beat(16)13
Avg EPS beat(16)16.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.84%
Revenue beat(8)2
Avg Revenue beat(8)-0.77%
Revenue beat(12)6
Avg Revenue beat(12)1.68%
Revenue beat(16)10
Avg Revenue beat(16)5.33%
PT rev (1m)-2.08%
PT rev (3m)-15.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.12%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-1.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE 15.69
Fwd PE 14.06
P/S 3.59
P/FCF 14.88
P/OCF 12.76
P/B 3.13
P/tB 44.99
EV/EBITDA 11.83
EPS(TTM)4.13
EY6.38%
EPS(NY)4.61
Fwd EY7.11%
FCF(TTM)4.35
FCFY6.72%
OCF(TTM)5.08
OCFY7.84%
SpS18.07
BVpS20.73
TBVpS1.44
PEG (NY)3.46
PEG (5Y)1.45
Profitability
Industry RankSector Rank
ROA 6.51%
ROE 12.05%
ROCE 13.02%
ROIC 10.33%
ROICexc 13.15%
ROICexgc 47.7%
OM 24.43%
PM (TTM) 13.83%
GM 56.44%
FCFM 24.09%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score8
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 2.61
Debt/EBITDA 1.93
Cap/Depr 54.33%
Cap/Sales 4.01%
Interest Coverage 250
Cash Conversion 88.34%
Profit Quality 174.26%
Current Ratio 3.24
Quick Ratio 2.52
Altman-Z 3.87
F-Score8
WACC8.12%
ROIC/WACC1.27
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
EPS Next Y4.53%
EPS Next 2Y6.28%
EPS Next 3Y7.67%
EPS Next 5Y5.71%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%
Revenue Next Year1.24%
Revenue Next 2Y3.06%
Revenue Next 3Y3.78%
Revenue Next 5Y4.75%
EBIT growth 1Y11.01%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year13.56%
EBIT Next 3Y8.09%
EBIT Next 5Y6.92%
FCF growth 1Y15.42%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y17.99%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%